Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had revenue of $38.78M in the quarter ending September 30, 2024, with 7.70% growth. This brings the company's revenue in the last twelve months to $148.44M, up 1.77% year-over-year. In the year 2023, Karyopharm Therapeutics had annual revenue of $146.03M, down -7.03%.

• Revenue (ttm): $148.44M
• Revenue Growth: +1.77%
• P/S Ratio: 0.55
• Revenue / Employee: $456,745
• Employees: 325
• Market Cap: 86.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	146.03M	-11.04M	-7.03%
Dec 31, 2022	157.07M	-52.75M	-25.14%
Dec 31, 2021	209.82M	101.73M	94.12%
Dec 31, 2020	108.09M	67.19M	164.31%
Dec 31, 2019	40.89M	10.56M	34.80%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.